
New ecopipam analyses show tic reduction within 8 weeks and sustained to 18 months in Tourette syndrome as the FDA weighs approval.
Children diagnosed with autism spectrum disorder are 9 times more likely to present to the emergency department (ED) for psychiatric reasons.






